Advancing
Peptide
Therapies
»
Press Releases
29-May-2009
Unigene Draws Down Remaining $5 Million from Non-Convertible Debt Financing
29-May-2009
Unigene's First Site-Directed Bone Growth Patent Issues
14-May-2009
Hot Flashes May Prompt Closer Look at Bone Health
11-May-2009
Unigene Reports Financial Results For First Quarter 2009
Concept
to
Commercialization
»
Why Unigene
»
Our Products
»
Stock Quote
»
Events
© Copyright 2005-2008 Unigene, Inc. ▪
Legal
